-
The National Biomanufacturing Network is a coordinated, national network that spans the bioinnovation ecosystem from end to end, with support for non-profit, for-profit, and dual-use applications. The NBN unifies access to distributed biomanufacturing infrastructure across Canada, with mission-driven funding and shared objectives to meet national priorities.
-
The purpose of the National Biomanufacturing Network Committee is to advise the SynBio Canada Board on the development of a coordinated national biomanufacturing ecosystem for Canada. The Committee will focus on advancing three interrelated pillars: (i) reagent development and distribution, including DNA, strains, cell lines, and synthetic DNA sequence screening; (ii) biofoundry capacity, including high-throughput design-build-test-learn infrastructure; and (iii) bioprocessing capacity, including pilot-scale and large-scale production. The Committee will support the integration of these pillars to accelerate the full bio-innovation cycle and strengthen biomanufacturing as a strategic national capability.
-
Develop a coordinated national biomanufacturing ecosystem across reagent development and distribution, biofoundry capacity, and bioprocessing capacity, and lead implementation of initiatives that advance these priorities with support from SynBio Canada. Reports to the Board of Directors of SynBio Canada.
Sean Sears (Chair of Organizing Board) - CEO, Clever Fermentation, Nova Scotia
Benjamin Scott (Organizing Board Member) - Platform Lead, Engineering Biology & Automation, Global Institute for Food Security, Saskatchewan/Ontario
Scott Pownall (Organizing Board Member) - Founder, Open Science Network Society, British Columbia
Click here for more information on the team.
-
Provide senior-level strategic guidance on the development of the national biomanufacturing ecosystem, helping establish priorities, build national support, and position biomanufacturing as a strategic Canadian capability.
Click here to meet the team.
-
The Canadian Reagent User Network (RUN).
RUN is a SynBio Canada-led pilot program designed to fundamentally change how biological reagents are developed and shared in Canada. RUN is establishing the infrastructure for a new model of biotechnology. One in which biological tools can be built, shared, and reused across the country.
Canada has invested billions of dollars in world-class biotechnology research, contributing thousands of biological reagents each year, including plasmids, microbial strains, enzymes, and other foundational research tools. Many of these resources, often developed through publicly funded research, remain difficult to access because of distribution barriers, shipping costs, and restrictive material transfer agreements (MTAs).
RUN is an early and 1st deliverable and one of three pillars of the National Biomanufacturing Network (NBN) committee.
By making proven biological tools easier to access and reuse, RUN aims to unlock greater value from Canada's research investments and strengthen domestic biomanufacturing. It is a practical step to build scientific sovereignty, keeping innovations accessible to Canadian non-profit and commercial development, creating an asset to be harnessed for nation-building applications.